| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 13.35× | 13.35× | 12.85× | 10.60× | 10.54× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| −2.61× | −2.50× | −1.53× | −1.87× | −2.16× | ||
| 0.40× | 0.40× | 0.36× | 0.34× | 0.34× | ||
| 3.61× | 3.61× | 2.62× | 9.22× | 5.32× | ||
| 1.02× | 1.02× | 1.06× | 1.01× | 0.92× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 10.54 | 10.60 | 12.85 | 13.35 | 13.35 | |
| Working Capital Turnover | -2.16 | -1.87 | -1.53 | -2.50 | -2.61 | |
| Asset Turnover | 0.34 | 0.34 | 0.36 | 0.40 | 0.40 | |
| Cash Conversion (CFO/Net Income) | 5.32 | 9.22 | 2.62 | 3.61 | 3.61 | |
| CFO/EBITDA | 0.92 | 1.01 | 1.06 | 1.02 | 1.02 |